Tian W, Ning J, Chen L, Zeng Y, Shi Y, Xiao G, He S, Tanzhu G, Zhou R#. Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States. Front Pharmacol. 2024 Feb 5;15:1333128. doi: 10.3389/fphar.2024.1333128. PMID: 38375030 (JCR1区 IF=5.6)
发布时间：2026-10-01
点击次数：
是否译文：否
上一条： Niu L, Wu H, Gao R, Chen L, Wang J, Duan H, Long Y, Xie Y, Zhou Q, Zhou R#. Optimal sequence of LT for symptomatic BM in EGFR-mutant NSCLC: a comparative study of first-line EGFR-TKIs with/without upfront LT. J Cancer Res Clin Oncol. 2024 Feb 19;150(2):94. doi: 10.1007/s00432-023-05538-9 PMID: 38369644 (JCR2 区 IF=3.6)
下一条： Shi, W., Tanzhu, G., Chen, L., Ning, J., Wang, H., Xiao, G., Peng, H., Jing, D., Liang, H., Nie, J., Yi, M., Zhou R#. (2024). Radiotherapy in Preclinical Models of Brain Metastases: A Review and Recommendations for Future Studies. International Journal of Biological Sciences, 2024 Jan 1; 20(2), 765-783. doi: 10.7150/ijbs.91295. PMID: 38169621. (JCR1区 IF=11.7)